IC-MPGN Recruiting Phase 2 Trials for Pegcetacoplan (DB16694)

IndicationStatusPhase
DBCOND0106988 (IC-MPGN)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs